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Background and Objective: New and more efficient methods of gene editing have
intensified the ethical and legal issues associated with editing germlines. Yet no research
has separated the impact of hereditary concern on public attitudes from moral concern.
This research compares the impact these two concerns have on public attitudes across
five applications including, the prevention of human disease, human and animal research,
animals for the use of human food and the enhancement of human appearance.
Methods: A sample of 1004 Australians responded to either a telephone (n = 501;
randomly selected) or online survey (n = 503; sourced by Qualtrics). Both samples were
representative in terms of States and Territories as well as gender (51% female), though
the online sample was younger (M = 40.64, SD = 16.98; Range = 18–87) than the
telephone sample (M = 54.79, SD = 18.13; Range = 18–96). A 5 (application) by 3
(type of cell) within groups design was utilized, where all respondents reported their
level of approval with scientists editing genes across the 15 different contexts. Multilevel
modeling was used to examine the impact of moral (embryo vs. germ) and hereditary
(germ vs. somatic) concern on attitudes across all applications.
Results: Australians were comfortable with editing human and animal embryos,
but only for research purposes and to enhance human health. The effect of moral
concern was stronger than hereditary concern, existing in all applications except for the
use of animals for human purposes. Hereditary concern was only found to influence
attitudes in two applications: improving human health and human research. Moral
concern was found to be accentuated amongst, women, more religious individuals
and those identifying as Australian, while hereditary concern was strongest amongst
non-Australians, those with stronger trust in scientists, and more religious respondents.
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Conclusion: Moral and hereditary concerns are distinct, and require different
approaches to public education, engagement and possibly regulation. Further research
needs to explore hereditary concern in relation to non-human applications, and the
reasons underlying cultural and gender differences.
Keywords: gene editing, public opinion survey, cell type, morality, germline, CRISPR-Cas9, multilevel modeling,
religiosity
INTRODUCTION
Since its first emergence in 2012, CRISPR-Cas9 (clustered
regularly interspaced short palindromic repeats) has become the
most dominant of a suite of new generation of genetic editing
methods. Extensive media and scholarly comment have declared
that CRSISPR-Cas9 will “supercharge” our understanding of
biological life. A multitude of applications and “breakthroughs”
are predicted, including the elimination of pests and diseases,
advances in food production, improved human health, and even
changes to the course of evolution (Funnell, 2016; Park, 2016;
Doudna and Sternberg, 2017). These claims are not new, with
the promise of cures for diseases and more nutritious food crops,
for example, existing since the advent of genetic engineering in
the 1970’s (Hogan, 2016). Relative to earlier methods however,
the reduced cost, enhanced efficiency and ease of use mean that
potentially any molecular biology laboratory can use CRISPR-
Cas9 to insert, replace or delete sections of DNA in any living
organism.
There are indeed signs that an explosion in CRISPR-Cas9
research has already commenced, with Science magazine’s 2015
“Breakthrough of the Year” already being employed to alter crops
(Cai et al., 2015) and animals (Whitworth et al., 2014) for food
production and the first clinical trials on humans beginning in
2016 (Cyranoski, 2016). The acceleration of CRISPR-Cas9 and
other gene editing techniques have however outpaced legal and
regulatory guidelines, especially in relation to heritable changes.
Scientists are therefore concerned that outdated legislation
and guidelines established prior to 2012 will impede progress,
particularly the development of much needed human genetic
therapies (Nicol et al., 2017). For example, modifications to
the genome within human embryos and germ cells that can
be theoretically inherited are considered especially promising
in eradicating genetic disorders and understanding human
development, yet this practice is currently restricted (in varying
degrees) in many jurisdictions (Isasi and Knoppers, 2015; Isasi
et al., 2016; Nicol et al., 2017).
In most jurisdictions, legislation attempting to guide the
ethical use of genetic engineering and human embryonic research
prior to 2012 was driven by political, economic, religious and
community pressure to protect the moral status of the human
embryo, and avoid potential dystopian outcomes such as human
clones, designer babies, genetic inequity and eugenics (Nuffield
Council on Bioethics., 2016). Legislation associated with the
modification of animal and plant genes was also associated with
pressure to prevent disruption to our ecosystem, environmental
damage and, importantly, to ensure the safety of genetically
modified organisms for human consumption (Tsatsakis et al.,
2017). With the availability of new gene editing methods, these
ethical legal and social concerns have intensified, especially
in relation to heritable edits of the human genome (Nuffield
Council on Bioethics., 2016). In 2014 the scientific community
was forced to confront these issues when Liang et al. (2015)
modified the gene responsible for a potentially fatal blood
disorder in 86 non-viable human embryos. The work was rejected
by both the prestigious journals Nature and Science partly due
to ethical issues, leading to a media frenzy and calls amongst
the scientific community for a moratorium on editing human
germlines (Cyranoski and Reardon, 2015). Acknowledging the
ethical concerns as well as the potential benefits, the US National
Academies of Sciences, Engineering, and Medicine convened
the Committee on Human Gene Editing: Scientific, Medical,
and Ethical Considerations to review the science, ethics and
governance of human genome editing. A comprehensive report
followed, culminating in guiding principles for governance,
and recommendations for the oversight and use of human
genome editing. While acknowledging that “basic laboratory
research involving genome editing of human cells and tissues is
critical to advancing biomedical science” (National Academies of
Sciences, 2017, p4), the report recommended that both somatic
and germline editing should only occur for the purpose of
preventing disease or disability. Germline editing was considered
only acceptable if there are compelling reasons and “a stringent
oversight system able to limit uses to specified criteria” (p13).
The NASEM report also recommended an ongoing
“reassessment of both health and societal benefits and risks,
with broad ongoing participation and input by the public”
(p178). Other scholars agree arguing, that “public sentiment
has considerable influence over allocation of resources, political
policy and participation rates in studies, all of which affect
the course of research” (McCaughey et al., 2016, p. 571).
More specific to gene editing, a survey of 301 attendees (74%
basic scientists) at a plenary entitled “Scientific, Clinical and
Ethical Implications of Genome Editing” at an American Heart
Association conference in 2017 found that 72% indicated that
they would not support “clinical applications of human germline
genome editing if the public was not asked about their opinion
on the issue” (Musunuru et al., 2017, p. 2). Lawyers and ethicists
also advocate public engagement to prevent a potential backlash
against media hype associated with germline editing obscuring
or biasing the potential benefits gained from gene editing somatic
cells within the clinic (Lanphier et al., 2015; Nicol et al., 2017).
The aim of this research was therefore to conduct a national
survey to extend our knowledge of attitudes toward gene
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editing, inform policy and, importantly, provide a voice for the
public.
A first step in considering public opinion is to determine
the extent of support and its drivers. Apart from a handful
of studies, little is currently known about lay perceptions of
gene editing of germline cells and embryos in humans or
animals. To date, only five peer reviewed surveys have been
published post 2012 (McCaughey et al., 2016; Gaskell et al.,
2017; Rose et al., 2017; Weisberg et al., 2017; Scheufele et al.,
2018), reporting results that coincide with earlier findings that
people tend to support genetic and genomic research generally
(including genetic engineering/modification) (Lucht, 2015) if it is
safe and the purpose is altruistic (e.g., to improve human health)
(Henneman et al., 2006; Condit, 2010). The first peer reviewed
study within the context of CRISPR also found more support
for therapeutic relative to enhancement applications, but support
for using embryos depended on the purpose (McCaughey et al.,
2016). Amongst a young (Median age= 24) predominately male
(62.1%) sample of 12,562 social media users across 185 countries
(primarily the US, UK, and China), McCaughey et al. found
that the majority supported editing cells in embryos to prevent
a debilitating (63%) or life threatening disease (63%) (And where
“all future generations would not have the disease”), and within
children or adults to cure a debilitating (59%) or life threatening
disease (59%) (And where “the disease could still be passed on
to their children”). Support was low for editing genes within an
embryo to alter any non-disease characteristics such as memory,
eye color or height (27%)1. They also found significantly greater
support for all applications amongst males, younger people and
those without a religious affiliation. Support for editing genes
to treat diseases was also significantly higher for those who had
finished a tertiary education and for those in wealthier countries2.
Self -reported wealth, however, was not associated with support,
nor was a family history of a monogenic Mendelian disease.
Gaskell et al. (2017) also found significantly high support in
2017 for therapeutic, relative to enhancement applications. An
online panel sample of 11,716 respondents across the US and
UK, Austria, Denmark, Germany, Hungary, Iceland, Italy, the
Netherlands, Portugal, and Spain was used to investigate the
perceived morality of different applications of gene editing. They
also found strong support for therapeutic applications and low
support for the purposes of enhancement across all countries.
Specifically altering “the gene sequence in some affected cells” to
improve symptoms of dementia in an adult patient (Median = 8
from a possible 11 point scale) and in an unborn child genetically
at risk for dementia (Median = 6) were viewed as more morally
acceptable than enhancing memory and learning capacities in
a healthy adult (Median = 2) or unborn child (Median = 0).
Altering the genes of adults was also viewed as more morally
acceptable than altering the genes of an unborn child, again in all
1Although this study also assessed attitudes towards genetically modified food,
the level of agreement for the question, “How much do you agree with the use
of genetically modified food?” was not reported.
2Prior knowledge of gene editing was also shown to be significantly associated with
support for the two adult and children disease conditions, but the direction of
the effect could not be ascertained as the question or coding of responses for this
question were not available.
countries. The level of moral acceptability was not significantly
associated with age or education, but females were generally less
supportive than males of all applications.
A recent (late 2016 and early 2017) national survey of
1600U.S. adults found similar results (Scheufele et al., 2018).
Higher approval was reported for therapeutic applications (e.g.,
human gene editing to treat humanmedical conditions or restore
health) than for human enhancement (e.g., human gene editing
to enhance or improve human abilities). Support was similar and
relatively high for both somatic and germline therapies. More
religious respondents and women were less supportive of gene
editing for both applications.
A fourth study utilized 1,249 online panel members (recruited
by Amazon’s Mechanical Turk) to investigate the impact of
metaphors or how genetic editing is framed (i.e., genetic editing,
genetic engineering, genetic surgery, and genetic hacking) on
beliefs in whether we should “be actively researching these
technologies” (−3= Absolutely not, 0= Unsure, 3= Absolutely
yes) (Weisberg et al., 2017). They also explored whether exposure
to the risks of gene editing3 influenced beliefs in whether the
technology should be used. They found, amongst the relatively
young (Median = 37.2 years), left wing and educated sample
of predominantly males, strong general support for gene editing
(M = 1.65, SD = 1.32). There were no differences in relation to
framing, but the study found support decreased for respondents
who received the vignette containing the risks (M = 1.43, SD =
1.36) relative to those who did not (M = 1.87, SD = 1.24). Men,
younger people, non-African Americans and those with more
than 4 years of college education and reporting a more left wing
political ideology were significantly more supportive. Having a
genetic disease or being related to someone with a genetic disease
was not associated with support.
Finally, two studies reporting on participants of public
scientific engagement events also reported strong support. The
first was conducted with 183 members of the US public who
participated in the 2015 Wisconsin Science Festival. A total of
34 participants attended a panel discussion including scientists,
academics and ethicists on human gene editing titled “Designer
Genes: Should We Be Able to Edit Our Genomes?” A survey
administered to the participants before (n = 34) and after (n =
26) the festival found that participants’ generally believed that
“genetic editing is morally acceptable” (M = 3.38, SD = 1.00; 1
= Strongly Disagree−5 = Strongly Agree), and that this belief
increased significantly after the panel discussion (M = 4.00, SD
= 0.71). Knowledge of gene editing also significantly increased
after the event as well as perceptions that there are both benefits
and risks to society.
Another evaluation of 57 public attendees to an Australian
Q and A expert panel discussion on gene editing (as part of
the Sydney Science Festival) also found support for editing the
genes of adults and children for clinical trials, human embryos for
research, and animals for research (Treleaven and Tuch, 2018).
The majority also approved of the use of gene editing within
human embryos to improve health and where the embryo is
3The risks stated were: For individuals, it could have unintended consequences, or
lead to unexpected mutations. For society, it could lead to eugenics.
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allowed to develop into a baby, although support was lower
for this than other applications. Respondents did not agree that
altering human embryos for enhancement purposes (i.e., gender
selection, eye color) was acceptable. Although support appeared
to increase for altering the genes of embryos after the discussion,
the differences were not significant.
Research examining public opinion relating to new forms of
genomic editing is therefore in its infancy. Emerging evidence
appears to suggest support varies according to the application
and particularly in relation to editing within human embryos, but
this also appears to vary alongside individual differences unique
to particular samples (i.e., those derived from online panels or
social media). There has also been no direct investigation into
the relative influence of both the source of cell (human, animal,
embryo, reproductive, somatic) and the purpose of editing
(to prevent disease, research purposes, enhance attributes). In
particular, there has been no attempt to separate the effects
of editing germ cells from those that occur within embryos.
Establishing greater public awareness of the distinction between
germline and somatic cell editing has been repeatedly emphasized
(Lanphier et al., 2015; Cartier-Lacave et al., 2016; Olson, 2016),
yet we know little about whether public support is influenced
by concerns about inherited edits being passed on to offspring.
Previous studies have only compared support for gene editing
somatic to embryonic cells (McCaughey et al., 2016; Gaskell et al.,
2017) which may confound concern with inherited edits with
moral or religious values attached to human embryos (Allum
et al., 2017).
We therefore directly investigated for the first time whether
public support for gene editing differs across somatic, germ
cells and embryos suggesting distinct underlying concerns.
Differences between germ and embryonic cells were defined as
concern for the moral status of the human embryo (referred
throughout as moral concern), while variation in support for
somatic compared to germ cells was considered concern for
passing edits on (referred to throughout as hereditary concern).
Using both a probabilistic population survey (randomly digit
dialed telephone interview) as well as an identical online
panel survey (sourced by Qualtrics), we also examined the
effect of cell type on attitudes in combination with different
applications: for research purposes only; to improve health
or prevent disease; in animals for human use; and for
human enhancement (e.g., to change appearance). Finally
we also explored the role of demographic and individual
difference variables (i.e., trust in scientists, political orientation,
knowledge) in explaining moral or hereditary concerns and
general support for gene editing. Whilst current research
suggests support will be lower for enhancement than for
improving human health, we had no prior expectations of
which factors and what combinations would be most important
in predicting support. Nevertheless, the ability to directly
compare multiple factors within the same study was expected
to shed light on which issues cause most concern, and
thereby provide valuable direction for policy makers keen to
address public confidence and trust in regulatory procedures
governing gene editing, and on where to direct educational
strategies.
MATERIALS AND METHODS
Participants and Procedure
A total of 1004 respondents were surveyed with an identical
measurement instrument, 501 via a computer assisted telephone
interview (CATI) and 503 via an online panel sample (OLP)
sourced through Qualtrics4 Both samples were stratified by state
and territory, with the OLP being also stratified by gender. The
CATI survey consisted of randomly generated mobile (43.5%)
and landline (56.5%) numbers sourced by Sampleworx5 The
response rates for the CATI survey according to the American
Association for Public Opinion Research (2009) definitions and
calculations (i.e., RR1–RR4) ranged from 6.0 to 9.0% with a
cooperation rate of between 13.8 and 15.4%.
CATI and OLP respondents were not significantly (at p <
0.05) different in terms of state and territory, gender (CATI =
51.3% female; OLP = 51.1%), and political orientation (CATI:
M = 5.00, SD = 2.17; OLP: M = 4.97, SD = 2.12; Range:
1 = Left wing−10 = Right wing). The CATI sample (M =
54.79, SD = 18.13; Range = 18–96) was however significantly
(p < 0.001) older than the OLP sample (M = 40.64, SD =
16.98; Range = 18–87), more likely to have a university degree
(CATI: 47.9%; OLP: 36.0%), and less likely to state that their
ethnicity was Australian (CATI = 76%; OLP = 83.3%). The
OLP sample was more likely to be working full (38.2%: CATI =
28.9%) and part time (20.9%; CATI = 15.7%), engaged in home
duties (9.9%; CATI = 3.4%) and unemployed (10.9%; CATI =
6.8%), while the CATI sample were more likely to be retired
(36.5%; OLP = 12.5%). The CATI sample also reported being
significantly (p < 0.001) more spiritual (CATI: M = 2.67, SD
= 1.17; OLP: M = 2.33, SD = 1.06; Range = 1 = Spirituality is
not at all important−4= Very important), though there were no
differences in church attendance (apart from weddings, baptisms
or funerals) (p = 0.877) or trust in the churches (p = 0.10).
There were no significant differences between samples in terms of
their self-reported knowledge of gene editing or trust in scientists.
Both groups demonstrated relatively low knowledge on a 10-
point scale where 0 = I know nothing about gene editing and
10 = I know a great deal about gene editing (CATI: M = 2.80,
SD = 2.57; OLP: M = 2.91, SD = 2.71). Trust is scientists was
relatively high for both groups (CATI:M= 3.83, SD= 0.99; OLP:
M = 3.70, SD = 1.05) in response to being asked “how much
do you trust scientists” (0 = Don’t trust at all−5 = Trust a very
great deal) (see Supplementary Materials for actual wording of
all questions).
Materials
The survey questions were included in the 2017 Swinburne
National Technology and Society Monitor, and were identical for
the CATI and online sample. Before introducing the topic of gene
editing, all respondents were asked about their knowledge of gene
editing and were then read the following information:
“Genome editing is when scientists deliberately alter the genes
in a living cell to change how a gene functions. So far most uses
4Qualtrics online panels. Available online at: https://www.qualtrics.com/au/
online-sample/
5Sampleworx.
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of gene editing have been for research purposes only, however
there are many possible applications. For example, it could be
used to alter the genes of plants and animals to increase resistance
to disease. It could also be used to develop new drugs, prevent the
inheritance of diseases, and determine the attributes of babies.”
Questions were designed to vary across the type of application
(improving health, research only, changing appearance and
animals for food) and cell source (embryo, germ cell, somatic
cell). Respondents were first asked about cells or embryos where
the edit could be inherited. Specifically they were asked, “The
first lot of scenarios relate to editing genes that could potentially
lead to the change being inherited (passed onto another human
or animal).” They were then presented with 10 different options
(described below) that varied by source and aim, and asked, “For
each of the following do you agree with editing the genes of:” The
presentation of each option was random across respondents, and
the response options were: Strongly Disagree = 1, Disagree = 2,
Agree= 3, Strongly Agree= 4, and Unsure.
In this section, two items assessed the application of
improving health or preventing disease: “Human embryos
[reproductive cells (i.e., egg or sperm)] to improve health or
prevent disease.” For research purposes four items were used to
assess attitudes across embryos and reproductive cells and animal
and humans. That is, “Human [Animal] embryos for research
purposes only” and “Human [Animal] reproductive cells (egg
or sperm) for research purposes only.” Enhancing attributes was
assessed by two items: “Human embryos [reproductive cells (i.e.,
egg or sperm)] for reasons of producing a baby with certain genes
e.g., for hair color, gender selection.” Finally, two items measured
differences in source across the aim animals for human purposes,
“Animal embryos [reproductive cells (i.e., egg or sperm)] for
human purposes (e.g., improving the quality of beef).
Participants were then asked about somatic cells. Specifically,
interviewers read out the following:
“The next lot of scenarios relate to editing the genes within
a somatic/body cell that cannot pass on the change to another
human or animal. For each of the following again, let us know the
extent to which you agree or disagree with editing the genes of:”
Six scenarios were randomly presented that assessed attitudes
across the five aims. That is, “A human body cell (e.g., eye or heart
cell) to improve health or prevent disease (e.g., blindness)?”, “A
human [animal] body cell for research purposes only,” “A human
body cell to change one’s appearance,” and “An animal body cell
to alter its characteristics for human purposes (e.g., leaner beef in
cows).”
RESULTS
Preliminary Analyses
To check for significant differences across the CATI and OLP
samples, a series of one way analyses of covariance (ANCOVA)
were computed for all 15 scenarios using SPSS Version 25. The
demographic differences between the two samples determined
the covariates since differences in support may be due to
differences in age, education or ethnicity for example rather than
because of the different survey administration. A series of binary
logistic regression equations suggested that the differences in
employment status across CATI and OLP respondents was due
to older people being more likely to be retired and less likely to
be working full or part time and unemployed. Differences across
the groups in education, ethnicity, spiritual beliefs, and home
duties were independent of differences in age. Thus, all (except
for occupational status) were used as covariates along with age
in the ANCOVA analyses. After controlling for the demographic
factors, the results revealed no significant differences in mean
agreement across the two samples in all but one of the 15
scenarios (see Table 1 for the adjusted means across samples).
The exception was for human embryos for research purposes,
where support was significantly, though only slightly higher (p=
0.028) for the CATI (M = 2.63, SE = 0.04) than OLP sample (M
= 2.48, SE= 0.05). Given the lack of differences it was decided to
combine the two samples for all subsequent analyses.
Table 1 suggests that, for both samples, support dropped
markedly for applications involving altering human cells to
change appearance and altering animals for human purposes.
All means for both samples were below the midpoint of 2.5
for these applications, and above for all other applications.
Support appears particularly high for applications aimed at
improving human health across all three cell types. The OLP was
significantly more likely to select unsure to nearly all scenarios
apart from those involving editing of germ and somatic cells
for human research purposes and changing appearance, and
editing embryos of animals for human purposes. This was after
controlling for the effects of all covariates in a binary logistic
regression, comparing the probability of being unsure relative
to providing an answer across the OLP and CATI samples. This
is likely due to a modality difference between the online and
phone surveys where “unsure” was presented as a response option
for the OLP but not for CATI (although it was accepted if a
respondent stated to an interviewer that they were unsure).
Predicting Attitudes
To assess change in attitude across cell type within each
application, a multilevel model approach (Bryk and Raudenbush,
1992; Goldstein, 1995; Longford, 1995 using MLWIN Version
1.10; Rasbash et al., 2001) was employed. Two analyses were
undertaken, the first to assess whether support for gene editing
differed across cell type and application separately (i.e., main
effects), and whether variation across cell type depends upon the
aim (i.e., interaction effects). The second set of analyses examined
the ability of the demographic and individual differences factors
to predict variation across cell type. Both analyses utilized a
three level model where variation in the outcome variable (gene
editing support) across respondents was level 3, variation across
applications was level 2, and variation across cell type was level 1.
Unsure responses in all models were treated as missing.
Moral and Hereditary Concern Across
Gene Editing Applications
Table 2 contains the results of the 3-level model that examined
the main effects of cell type and application as well as their
interaction on attitude. The reference category for cell type was
germ cell, meaning the parameter estimates for the predictor
embryo compared support for embryos to germ cells (indicating
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TABLE 1 | Adjusted mean support and percent unsure for all scenarios across CATI and OLP samples.
CATI OLP
Application Cell type Mean SE n Unsure % Mean SE n Unsure %
Improve Health or prevent disease Embryo 3.07 0.04 450 7.2 2.97 0.04 451 10.3*
Germ 3.15 0.04 465 4.0 3.06 0.04 465 7.6**
Somatic 3.21 0.03 475 1.8 3.15 0.03 479 4.8**
Research purposes only (Human Cells) Embryo 2.63 0.04 453 6.4 2.48◦ 0.05 428 14.9***
Germ 2.82 0.04 444 8.6 2.80 0.04 445 11.5
Somatic 2.85 0.04 459 5.2 2.90 0.04 462 8.2
Research purposes only (Animal Cells) Embryo 2.80 0.04 454 6.2 2.75 0.04 436 13.3**
Germ 2.85 0.04 466 4.0 2.81 0.04 450 10.5**
Somatic 2.83 0.04 459 5.2 2.85 0.04 457 9.1*
Change Appearance (Human cells) Embryo 1.74 0.04 474 2.6 1.84 0.04 468 7.0*
Germ 2.01 0.04 446 8.0 2.12 0.04 449 10.7
Somatic 1.97 0.04 466 4.2 1.90 0.04 465 7.4
Animals for human purposes (food) Embryo 2.41 0.04 435 10.2 2.38 0.04 440 12.5
Germ 2.41 0.04 442 8.6 2.40 0.04 442 12.1*
Somatic 2.28 0.04 451 6.8 2.29 0.04 446 11.3**
Means are adjusted for age, education, ethnicity, spiritual beliefs and home duties. ◦= ANCOVA results revealed mean was significant from CATI sample at p < 0.05; SE, Standard
Error; Range for attitude, Strongly Disagree = 1, Disagree = 2, Agree = 3, Strongly Agree = 4. *Results of binary logistic regression predicting unsure compared to provided an answer
across OLP and CATI samples (controlling for age, education, ethnicity, spiritual beliefs and home duties) significant at p < 0.05, **p < 0.01, ***p < 0.001.
moral concern), and those for somatic cell compared support
for germ cells with somatic cells (indicating hereditary concern).
Application predictors were constructed to reflect deviation
contrasts or change in support across a specific aim (e.g.,
Improving health) compared to all other aims. Cell type by
application interactions were used to assess whether any change
in support across cell type depended on the gene editing
application. Separate models were computed for each application
(using deviation contrasts) and the results are shown in
Table 2.
The random effects in Table 2 for the Null model reveal that
there was significant variation in support for gene editing across
applications and cell type and, as would be expected, across
respondents. The relative size of the effects reveals that overall
what gene editing is used for (i.e., the application) has a greater
influence on support compared to the type of cell (0.36 vs.
0.26). In relation to the main effects for application, models 2–6
reveal that in comparison to all other applications (and averaged
over cell type), support was significantly higher for improving
human health, and for human and animal research (see Figure 1
for predicted means resulting from the estimates in Table 2).
Support was significantly lower for enhancement and the use of
animals for food. The fixed, main effect for cell type in Model 1
reveal that, averaged over all applications, there was significantly
higher support for gene editing when scientists use germ cells
compared to embryos, suggesting that the level of support for
gene editing is dependent on moral concerns for the embryo.
Model 1 also suggests that there was no significant difference
between germ and somatic cells, thereby providing no evidence
that hereditary concerns influence support for gene editing in
general.
The pattern of results for the interaction effects, however,
reveal that in some contexts, hereditary concerns may matter.
When scientists use gene editing to improve human health or
prevent disease, the somatic by health interaction (in Model
2) was significant. This suggests that support increases when
somatic cells are used relative to germ cells when gene editing
is used to improve human health, but when it is used for other
purposes, the tendency for support to be higher for somatic
relative to germ cells is not apparent (see Figure 1). In other
words, hereditary concerns are important when gene editing is
used to improve human health and for human research but not
for animal research, enhancement, or using animals for food.
There were no significant somatic vs. germ cell differences for
animal research, but unexpectedly for human enhancement and
using animals for food, the significant somatic cell interactions
revealed that support was higher for germ than somatic cells (see
Figure 1).
The interactions relating to embryos (relative to germ cells)
were also significant across all applications. Gene editing in
embryos generated significantly lower support than germ cells
across all applications except animals for food, but the extent
of this effect varied across applications (see Figure 1). The
effect was largest for human research and human enhancement
(represented by the negative interaction effect), and smallest for
human health and animal research. There was no difference in
support for embryos relative to germ cells for the use of gene
editing in animals for food.
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TABLE 2 | Parameter estimates for predicting support for gene editing across application and cell type.
Effect Null
model
Model 1
(cell type)
Model 2
(health)
Model 3 (human
research)
Model 4 (animal
research)
Model 5
(appear-ance)
Model 6 (animals
for food)
Intercept 2.58(0.02) 2.63(0.02) 2.52(0.02) 2.59(0.02) 2.59(0.02) 2.78(0.02) 2.69(0.02)
FIXED EFFECTS
Embryo −0.13(0.01) −0.14(0.01) −0.11(0.01) −0.15(0.01) −0.09(0.01) −0.16(0.01)
Somatic –0.02(0.01) −0.04(0.01) −0.03(0.01)* –0.02(0.01) 0.01(0.01) 0.01(0.01)
Health 0.57(0.03)
Health × Embryo 0.06(0.02) *
Health × Somatic 0.12(0.03)
Human Res. 0.20(0.03)
Human Res. × Embryo −0.13(0.03)
Human Res. × Somatic 0.09(0.03)
Animal Res. 0.23(0.03)
Animal Res. × Embryo 0.10(0.03)
Animal Res. × Somatic 0.03(0.03)
Enhancement −0.71(0.03)
Enhancement × Embryo −0.17(0.03)
Enhancement × Somatic −0.13(0.03)
Animals for food −0.29(0.03)
Animals for Food × Embryo 0.16(0.03)
Animals for Food × Somatic −0.11(0.03)
RANDOM EFFECTS
Level 3 Respondent 0.21(0.01) 0.21(0.01) 0.22(0.01) 0.21(0.01) 0.21(0.01) 0.23(0.01) 0.21(0.01)
Level 2 Application 0.36(0.01) 0.36(0.01) 0.28(0.01) 0.35(0.01) 0.34(0.01) 0.22(0.01) 0.34(0.01)
Level 1 Source 0.26(0.00) 0.26(0.00) 0.26(0.00) 0.26(0.00) 0.26(0.00) 0.26(0.00) 0.25(0.00)
−2*loglikelihood 29570.5 29397.13 28600.65 29268.9 29255.88 27969.17 29167.65
The fixed effects for Embryo, Somatic, Health, Food, Human Research, Animal research, appearance, and Animals for food represent main effects. Effects with “×” represent interactions.
Standard errors are contained within parentheses. All parameters were significant at p < 0.001 unless otherwise stated. *p < 0.01. Bolded parameters were not significant at p < 0.05.
The −2* loglikelihood value represents overall model fit, with lower values representing better fit. The Null model is a model that contains no predictor variables. N was 923 for all models.
Individual Differences in Moral and
Hereditary Concern
The second set of analyses examined individual difference
predictors of variation in support for gene editing across cell type.
The first model contained the following fixed effect predictors
entered simultaneously: CATI vs. OLP sample; Embryo vs. Germ
Cell; Somatic vs. Germ Cell; Age, Gender, Education, Religion,
Ethnicity, Gene Editing Knowledge, Political Orientation and
Trust in Scientists (see Table 3 for parameter estimates).
A second model added interactions between the individual
difference factors and the two cell type predictors, embryo and
somatic, to investigate whether moral or hereditary concern
varied across different respondents. Given that hereditary
concerns were only found to occur in gene editing to improve
human health and human research, a third model was tested
using only these two applications in the analysis. Interactions
were entered one at a time in the order presented in
Table 3. If the interaction was significant at p < 0.05 it was
retained in the model. Table 3 shows the results for the final
models.
The fixed main effects for the individual difference variables
in Table 3 for Model 1 suggest that attitudes toward gene editing
significantly vary according to age, gender, religion, knowledge
and trust in scientists. Averaged over cell type and application,
higher support was evidenced amongst younger people, males,
those with lower religiosity, and those with more self-reported
knowledge and trust in scientists. Education, ethnicity and
political orientation were not associated with general support for
gene editing. The interaction effects for Model 2 averaged over
all applications in Table 3 suggest that only gender and ethnicity
were significantly associated with moral concern. Specifically, the
predicted means (derived from the regression equation) show
that males (Y′ = 2.38) and females (Y′ = 2.23) demonstrated
similar support for gene editing using germ cells, but support
was lower amongst females (Y′ = 2.11) than males (Y′ = 2.32)
for the use of embryos. This suggests that the moral status
of the embryo was more of a concern for females (Y′embryo-
Y′germ = −0.12) than males (Y
′
embryo-Y
′
germ = −0.06). The
predicted means for ethnicity also show that moral concern was
stronger for Australians (Y′embryo [2.05]-Y
′
germ [2.26] = −0.21)
compared to non-Australians (Y′embryo [2.11]–Y
′
germ [2.31] =
−0.12).
Interestingly, when only the applications of improving human
health and human research were analyzed, the interaction effects
in Model 3 show that moral concern still differed across males
and females, but also across different levels of religiosity. An
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FIGURE 1 | Predicted mean support for gene editing across cell type and aim. Other refers to the average of all applications minus the comparison application.
effect for ethnicity was no longer significant, suggesting that
Australians demonstrate greater moral concern overall, but not
when the purpose of the editing is to improve human health
or human research. The predicted means for gender show that
moral concern was stronger for women (Y′embryo [2.29]–Y
′
germ
[2.54] = −0.25) compared to men (Y′embryo [2.45]–Y
′
germ [2.61]
= −0.16) when the purpose of gene editing is for human health
and research. The predicted means for religion showed that as
religiosity increased the gap between support for using embryos
compared to germ cells increased (see Figure 2). Thus, greater
moral concern was associated with stronger religiosity when gene
editing is used to improve human health and human research.
In relation to hereditary concern, the interaction effects in
Model 2 in Table 3 reveal that variation in support across
somatic vs. germs cells was significantly associated with ethnicity,
trust, and religion. Interestingly, this was only the case when
all gene editing applications were included in the analysis.
When only human health and research were examined, there
was no evidence for hereditary concerns either across the
entire sample or amongst specific individual difference groups.
The predicted means for ethnicity (using the coefficients from
Model 2) showed a reversed hereditary concern effect, in that
averaged over all aims, support for germ cells was higher than
somatic cells. This was the case for both Australians and non-
Australians, but the difference was greater for Australians (0.13)
than non-Australians (0.05). The predictedmeans for the effect of
religiosity revealed that hereditary concern increased alongside
stronger religiosity. For example, for those who scored zero
on religiosity, support for germ cells was greater than somatic
cells (0.08). This difference however decreased with stronger
religiosity, disappearing for those who scored on the extreme end
of the scale (i.e., religiosity = 5) (−0.03). The effect for trust in
scientists showed higher predicted support for germ relative to
somatic cells for those demonstrating low levels of trust (i.e., trust
= 0) (0.07), whilst slightly higher support for somatic relative to
germ cells was estimated for those reporting high levels of trust
(i.e., trust= 5) (−0.04).
DISCUSSION
In general, the results of this Australian survey correspond with
US and European findings, suggesting public support for gene
editing depends on the application (McCaughey et al., 2016;
Gaskell et al., 2017). That is, support is relatively high when the
purpose is to enhance human health, and low when the purpose
is to enhance attributes or appearance in otherwise healthy
individuals. Extending on existing knowledge, we also found the
sample supported editing genes within the context of animal as
well as human research, and that both generated significantly
more support than enhancing human appearance and animal
attributes for the purpose of improving human food. These
results coincide with general research suggesting that Australians
demonstrate consistently high levels of trust in scientific research
(Bruce and Critchley, 2003–2017), general support for the use
of animal models in medical research (under certain conditions)
(Critchley et al., 2013) and a distaste of designer babies and
genetically modified animals for food (Marques et al., 2015).
They also validate the findings generated from recent online
panel studies, given the similarities we found between our OLP
and CATI samples (after statistically controlling for demographic
differences).
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TABLE 3 | Parameter estimates for predicting variation in support across cell type
from individual differences.
Effect Model 1 Model 2 Model 3
(human health and
human research only)
Intercept 2.20(0.09) 2.24(0.10) 2.43(0.13)
FIXED EFFECTS
MAIN EFFECTS
OLP −0.01(0.03) −0.01(0.03) −0.03(0.04)
Embryo −0.12(0.01)*** −0.12(0.05)* −0.12(0.08)
Somatic −0.02(0.01) −0.139(0.05)** −0.06(0.08)
Age −0.002(0.001)*−0.002(0.001)* −0.002(0.001)*
Female −0.18(0.03)*** −0.15(0.03) *** −0.07(0.04)
University educated 0.03(0.03) 0.03(0.03) 0.02(0.04)
Religionψ −0.06(0.01)*** −0.06(0.01)*** −0.08(0.02)***
Australian −0.02(0.04) −0.03(0.04) 0.05(0.05)
Knowledge 0.02(0.006)*** 0.02(0.006)*** 0.015(0.008)
Political orientation 0.01(0.01) 0.01(0.01) 0.01(0.01)
Trust in Scientists 0.18(0.02)*** 0.17(0.02)*** 0.19(0.02)***
INTERACTIONS
Embryo × Female −0.06(0.02)** −0.09(0.04)*
Somatic × Female −0.03(0.02) −0.01(0.04)
Embryo × Religion −0.003(0.01) −0.037(0.015)*
Somatic × Religion 0.02(0.01)* 0.02(0.015)
Embryo × Australian 0.06(0.03)*
Somatic × Australian 0.08(0.03)**
Embryo × Trust 0.004(0.01)
Somatic × Trust 0.02(0.01)*
RANDOM EFFECTS
Person 0.20(0.01) 0.20(0.01) 0.20(0.02)
Type 0.31(0.01) 0.31(0.01) 0.15(0.01)
Cell 0.25(0.00) 0.25(0.00) 0.26(0.007)
−2loglikelihood 25727.0 25696.6 9860.59
Standard errors are contained within parentheses. ψReligion consisted of the mean score
of church attendance, spirituality and trust in the churches (α= 0.73). The Null model was
identical to that presented in Table 2, so was not reported here. *p < 0.05, **p < 0.01,
***p < 0.001. n was 821 for all models.
Moral Concern Associated With Editing
Embryos
In line with other recent studies (Critchley et al., 2013; Treleaven
and Tuch, 2018) our results suggest that Australians are relatively
comfortable with the idea of editing human and animal embryos,
but only for research purposes or to enhance human health.
Editing human and animal embryos for the purpose of enhancing
human or animal attributes, respectively, was not supported.
Thus, this study aligns with earlier research suggesting that
Australians are generally supportive of embryonic research if
it will lead to cures for serious human disease (Critchley and
Turney, 2004; Critchley, 2008). Moral concern was however
found to occur in all applications assessed by this research except
for editing animal embryos for the purpose of improving human
food. The low support for this application combined with the
absence of a moral concern effect suggests the influence of other
factors.
Strong public opposition to genetically modified animals
for food has been consistently demonstrated within Australia
(Bruce and Critchley, 2003–2017; Marques et al., 2015) and
elsewhere (Schuppli et al., 2015), and has often been attributed
to unease associated with safety, animal welfare and low trust in
regulators (Kronberger et al., 2014; Shriver and McConnachie,
2018). It is possible, therefore, that these factors may override
the influence of moral concern for animal embryos when the
purpose is for human food. Moral concern did however reduce
support in the context of using animals for research. Perhaps
moral concern in a research context reflects concern with animal
welfare rather than safety or lower trust which are more likely
to occur within the context of genetically modified animals for
food.
In the two research contexts, the impact of moral concern
on support for gene editing was stronger for human compared
to animal embryos. While this may reflect a value orientation
emphasizing the importance of human life over all other forms
(at least for those opposed to embryonic researchmore generally)
(Kass, 1997), it does not support the findings of a national survey
of 2700 Australians that stem cell research using animal embryos
generated statistically equal levels of comfort (or discomfort)
as human embryos (Critchley et al., 2013). The fact that moral
concern was also less important for the application of enhancing
human health than the human research context may provide
a clue to this inconsistency. The human research condition
was articulated to respondents as simply, “do you agree with
editing the genes of human embryos for research purposes
only,” while the enhancing human health condition was, “human
embryos to improve health or prevent disease.” The question
relating to human research could have been interpreted as
including multiple purposes (including some that are potentially
undesirable such as cloning) resulting in higher concern for
the embryo than when health benefits are directly promised,
and where ethical concerns are more likely to be compromised
(Caulfield et al., 2006).
Similarly, an underlying willingness to compromise ethical or
moral principles if research is likely to cure disease may have
also explained the lower moral concern for animal embryos
in the research context. In the Australian study where similar
support was found for research using animal (i.e., mice) and
human embryos (Critchley et al., 2013), respondents were clearly
informed in both contexts that the aim of the stem cell research
was to find cures for untreatable diseases in humans. The
only other animal scenario included in this research was the
unpopular application of editing animal cells for the purposes
of human food. With the negative food application statistically
controlled for, the research purposes for animals could have been
perceived to include research that was beneficial for animals as
well as humans. Because no question assessing specific health
benefits using animals was included, this was not controlled for
as it was for human research. Thus, it was possible that animal
research was perceived to include more beneficial purposes on
average than human research (as preventing disease via human
editing was accounted for). Clearly future research is needed to
confirm this finding by also including a scenario where the use
of gene editing within animals is described as being conducted
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FIGURE 2 | Predicted mean support for gene editing across cell type and religiosity. 5 = Higher religiosity.
specifically to improve human health or animal health and
welfare.
Hereditary Concern
Previous studies have confounded hereditary andmoral concerns
by only using embryos (or unborn children) to compare with
somatic or adult cells (McCaughey et al., 2016; Gaskell et al.,
2017). The design of this study allowed for the separating of
these two effects to confirm for the first time, that public concern
about the moral status of the embryo is independent from any
hereditary concern. Although moral concern was found to be
more pervasive than hereditary concern, the latter was found
to be present for applications involving humans. Averaged over
all applications there was no significant difference in support
between cells that were specifically described as being able to
transmit edits to offspring (i.e., germ cells) and those that could
not (i.e., somatic cells). However, when human genes are edited
for the purpose of improving human health or for human
research, support for the use of germ cells was significantly less
than somatic cells. Gene editing animals for research or human
purposes did not generate concern for edits being passed on
to future generations. Although future research is needed to
examine the reasons for these findings, a possible explanation
for the lack of hereditary concern amongst animal applications is
that the breeding and behavior of domesticated research and farm
animals is tightly regulated within Australia, arguably posing
little threat that their modified genes will be transferred to the
wider ecosystem.
This is inconsistent however, with earlier research concluding
people are not comfortable with the possibility of genetically
engineered animals passing on harmful defects to offspring
(Schultz-Bergin, 2018). This would suggest hereditary concern
due to fear for the offspring’s welfare rather than detrimental
safety or environmental effects. If moral concern was associated
with welfare concern, then any worry about edited animals
passing on harmful effects to offspring may have been removed
when the effects of moral concern on gene editing support
were accounted for (at least in the animal research application).
Future research should therefore assess support for gene editing
within animals in additional contexts that directly specify the
potential for harmful consequences to the animal’s offspring
(e.g., the type of gene edited and resulting phenotype) as well
as the environment (e.g., gene editing in animals that are
not in captivity). Comparing reactions to the editing of non-
domesticated animals would also be helpful, particularly those
whose breeding could permeate the wider ecosystem.
Individual Differences in Support for Gene
Editing
Averaged over cell type and application, the current research
found significantly higher support amongst males, younger
people, and those reporting lower religiosity, more knowledge
and stronger trust in scientists. This supports the work of
McCaughey et al. (2016) as well as Weisberg who also found
amongst a sample of social media users and online panel
members, respectively, higher support for gene editing amongst
males and younger respondents. Gaskell et al. (2017) also found
higher support amongst males, but age was not associated with
attitudes. In line with the findings of McCaughey et al., we also
found that those with lower religiosity were more supportive. In
contrast to previous studies however (McCaughey et al., 2016;
Weisberg et al., 2017), and similar to the results reported by
Gaskell et al., higher support was not found to be associated with
higher education. Finally in contrast to Weisberg, a more left
wing political ideology was not associated with more support in
this study.
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Possible explanations for the demographic differences in
attitudes to gene editing in general are likely to be complex
involving psychological, socio-political and cultural factors
(Hartman et al., 2017). Indeed there is still debate within the
general attitudes toward science literature about why certain
demographic differences influence attitudes. The complexity is
also compounded by the different measures, analyses techniques
and combination of demographic variables used across studies
(Sturgis and Allum, 2001). For example Weisberg et al. found
that support for gene editing rose for those with a more left
wing political ideology but did not measure or control for
religiosity. We controlled for both of these correlated variables
(Rutjens et al., 2017) and found religiosity rather than political
orientation was important. Thus, understanding why certain
demographic characteristics may or may not influence attitudes
to gene editing also requires muchmore research including direct
comparisons of cultural or country differences in the importance
of predictors (especially religion and political orientation), as
well as comparisons across different types of samples. Indeed
our research demonstrated extensive differences between the
demographic background of the OLP and CATI surveys,
which could further alter the impact of certain demographic
variables on support. Despite this, our results add to previous
findings that males, younger respondents and those with more
education are more supportive of gene editing. Given that higher
support for science and emerging biotechnologies (including
GM foods) in general have also often been found amongst
these groups (Rutjens et al., 2017), future research should also
investigate whether gene editing is viewed differently from other
biotechnology applications amongst different groups or whether
this is simply a reflection of support for science in general
(Hartman et al., 2017).
In relation to moral concern for embryos, it was found
that women and those who were Australian born displayed
significantly more unease when all applications were considered.
However, when the application involved only human embryos
(for human health enhancement and human research) the effect
remained for gender but disappeared for ethnicity, and became
significant for those with stronger religiosity. This suggests that
women are more concerned than men about embryonic editing
regardless of its purpose, and that Australian born respondents
are only more concerned in applications involving animals and
enhancing human attributes. In support of previous research
indicating religious beliefs are associated with lower support
for embryonic research (Nisbet, 2005; Ho et al., 2008; Critchley
and Nicol, 2009; McCaughey et al., 2016) increasing discomfort
with editing embryos was displayed as religiosity increased. The
fact that religion did not significantly predict increased moral
concern for embryos when the application involved animals or
enhancing human attributes provides support for the idea that
even when the editing is being conducted to cure or prevent
disease, human embryos are considered sacred and morally
distinct from animal embryos for religious individuals.
The findings associated with gender and moral concern
coincide with previous findings that women are generally less
accepting of biotechnology and science in general than men.
The reasons for more general gender differences are not clear
and have been attributed to women’s lower interest, knowledge
and educational opportunities (Hayes and Tariq, 2000), decreased
trust in science and increased religiosity compared to men.
Some scholars have also suggested that gender differences are
due to men attributing more importance to science due to
stereotypical beliefs associating science with male rather than
female attributes (Rutjens et al., 2017). While we cannot assess
differences due to stereotypical beliefs, gender effects in this
study were still found to significantly reduce support for editing
embryos (in all applications) after removing the effects of
knowledge, trust, education and religion, thereby suggesting
alternative explanations.
Interestingly, Simon (2012) argues that women are
less supportive of biotechnology because they are more
likely than men to be directly affected by any negative
consequences. Potentially harmful outcomes of new and
untested biotechnological developments have more direct
implications for women’s bodies, their reproductive processes,
offspring and the selection and preparation of food. Feminist
scholars also point out that women’s bodies are often at
the center of biotechnological controversies, especially
reproductive technologies which are at particular risk of
increasing commodification of the human body (Kirejczyk,
2008). This may further generate an emotive “yuck factor”
type response amongst women providing another source of
discontent to explain their decreased support for research
involving embryos. These explanations remain speculative
however, as the complex reasons for gender differences in
relation to concerns for human and animal embryos need to
be further investigated. There are also other possible reasons
for gender differences, such as women being more sensitive
to genetic inequality given their historical oppression by men.
Research needs to directly capture the underlying values,
emotions, motivations and world views of both men and women,
and how they may interact with other contextual factors to drive
gender differences in support for gene editing.
There were no gender differences in hereditary concern
which is interesting given women’s consistent reduced general
support relative to men for a range of biotechnologies. Perhaps
the description of germ cells could have been attributed to
either gender effectively removing Simon’s (2012) gender salience
effect. General hereditary concern was however significantly
associated with ethnicity, trust and religion. Possibly reflecting a
general distaste toward scientists playing god, higher religiosity
was associated with greater hereditary concern. The result for
ethnicity was intriguing as both Australians and non-Australians
demonstrated a reverse hereditary effect in that editing germ cells
were viewed as more positive than somatic cells, but the effect
was even more pronounced for those reporting an Australian
identity.
After controlling for all demographic and individual
differences as well as moral concern and any associated welfare
concerns, the reverse hereditary effect may indicate that editing
germ cells is perceived to be more beneficial than containing
an edit within a somatic cell. Improving human attributes,
removing diseases or improving animals for food, if safe and
not morally objectionable (and conducted by trusted scientists),
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would have more impact if unwanted characteristics are no
longer passed onto future generations. The phrasing of the
information provided to respondents before they answered any
questions emphasized the ability of gene editing to prevent the
inheritance of disease and increase resistance. This may have
primed some respondents to view the passing on of desirable
edits as positive rather than negative, supporting Shriver and
McConnachie’s (2018) notion that new forms of gene editing
(especially within animals) may be viewed as more acceptable
due to not mixing species and a reduction in off-target edits
resulting in harmful consequences. They further argue that
increasing an understanding amongst the public of these issues
may therefore increase support for editing germlines in some
contexts if it were used in the interests of animal and human
welfare as well as the environment.
Clearly more research is needed to unravel why hereditary
concern may or may not translate into support for germline
editing. After statistically removing the effects of moral concern,
trust and religion, Australians were curiously even more
supportive of germline editing than other ethnic identities. An
explanation for this interesting result may be that Australian
ethnic identity could have acted as a proxy for other factors
associated with a preference for germ cells, such as increased
exposure to positive media portrayal of the benefits of gene
editing. But this is purely speculative and difficult to determine
given the vast array of ethnic identities contained in the
non-Australian category and the absence of measuring media
exposure in this study. It is also curious that increased knowledge
was associated with support overall, but was not associated with
reversed hereditary concern. If increased knowledge included an
awareness of the ability of more recent gene editing tools to
reduce ethical and safety concerns it should be associated with
more support for editing germ cells. Clearly what self-reported
knowledge (as measured in the current study) is measuring needs
to be examined, and more objective measures of knowledge
across a number of areas of gene editing should be constructed,
as well as instruments to capture the extent and type of media
exposure.
Another explanation for the reversed hereditary finding is
that it may be an artifact of a methodological effect. Support
for gene editing measures were presented to respondents in
two sections. The first described edits that can be passed onto
offspring and contained the embryo and germ cell questions
together. The second section contained only the scenarios with
somatic cells. By placing the embryo and germ cells together a
contrast bias may have occurred resulting in inflated support
scores for germ cells. The more emotionally charged embryo
examples may have been used as the perceptual anchor in which
to evaluate or compare the germ cell applications. If an individual
views embryo editing as undesirable, they may perceive the less
negative comparative option (i.e., germ cells) to be more positive
than they normally would (Skowronski and Carlston, 1989).
In other words to emphasize their negative orientation toward
embryos higher support is attributed to the apparent opposition
which was germ cells. Because negative behaviors or attributes
are more likely to be used as the perceptual anchor (Skowronski
and Carlston, 1989), and perceptions of them are less resistant to
change (Baumeister et al., 2001), it is more likely that an increased
positivity bias would be in effect for germ cells (Wänke, 1996)
rather than an inflation of disapproval for embryos. This could
therefore explain why support was higher for germ rather than
somatic cells in some applications.
Even higher support for germ relative to somatic cells was
found for those lower in trust. This is counter intuitive given that
it would be expected that those who do not trust scientists would
be more concerned about edits being passed on (if harmful). In
line with previous research in the wider biotechnology literature,
higher trust was strongly associated with greater support for gene
editing across all applications and cell types. After controlling
for all demographic and individual difference variables and the
significant interactions between the somatic/germ comparison
and ethnicity, religion and gender, the effect of trust on hereditary
concern may have inadvertently captured a susceptibility to a
contrast bias. After accounting for religion and gender which
were also associated with hereditary concern, lower trust in
scientists may have represented a range of factors responsible
for an increase in bias such as a general tendency for skeptical
individuals to polarize comparisons (Gunther, 1988), decreased
cognitive engagement with the survey questions (Bukovskaya
and Shmukler, 2016) or susceptibility to cognitive biases in
general (Spithoven et al., 2017). It would therefore be beneficial
for future research to reduce the potential for contrast effects by
using a between groups design where different individuals are
presented with each cell type and application.
CONCLUSIONS
This study has revealed that the nature of support for gene
editing is complex and determined by the application, the type of
cell and also individual differences. Importantly, it has revealed
for the first time, that concerns about edits being passed onto
human offspring are present alongside those associated with the
moral status of the embryo. It also suggests, albeit tentatively
that germline editing may not be controversial amongst some
members of the public if moral (and possibly other) concerns are
dealt with. One of the most important ethical issues arising from
the gene editing community is the risk of passing on unintended
or detrimental genetic modifications to future generations.
This is distinct from the use of embryos in research more
broadly, and as such requires a different approach to public
education and engagement. It also arguably supports the implied
recommendations of the International Summit on Human Gene
Editing that called for distinct regulatory responses to ensure the
protection of future living organisms and the environment, as
well as the protection of the embryo at one point in time. Current
bans in some countries on all germline editing may be considered
by a large majority of the public to be too restrictive. Our result
that hereditary and moral concern are independent therefore
suggests that policy makers and regulators keen to accommodate
public opinion should consider carefully the separate issues
involvedwith editing embryonic compared to other types of germ
cells.
The editing of somatic cells was found to be supported in
all applications assessed by this research apart from editing the
genes of animals for human use. This suggests that the likelihood
of public opposition to editing is low within the clinic where
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therapeutic developments by altering the genetic information
responsible for Mendelian diseases is currently most promising.
Though lower in some applications, support for editing cells
within gametes was also generally supported, though again not
within animals for human purposes. Although more research
is needed to validate the findings, this study implies that the
public do support edits that can be passed on to future offspring
and that this support may increase alongside an awareness of
new methods such as CRISPR-Cas9. That is, specific knowledge
relating to CRISPR-Cas9’s potential to reduce harmful off-target
edits and not needing to introduce the genetic material from
one species into another. Education and engagement strategies
targeting religious individuals and non-Australians may also
increase this support further.
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